Tuesday , September 22 2020
Home / Project Syndicate / The G20’s Pandemic Moment

The G20’s Pandemic Moment

Summary:
Just as a meager investment to address antimicrobial resistance could yield a 2,000% return in the future, so, too, would an immediate modest outlay to finance development of COVID-19 therapeutics. As world leaders gather to formulate a response to the crisis, they must not lose sight of this simple cost-benefit calculus. LONDON – This week, G20 leaders will convene virtually to discuss the COVID-19 crisis. One hopes that the emergency summit marks the beginning of a thoughtful collective response to this grave challenge. If so, the meeting may turn out to be even more consequential than the London summit hosted by British Prime Minister Gordon Brown in April 2009, which created the framework for a coordinated

Topics:
Jim O'Neill considers the following as important:

This could be interesting, too:

Miles Kimball writes Hypotheses about Salt and Blood Pressure

John H. Cochrane writes Jacobin pandemic

Timothy Taylor writes An Overview of Emergency COVID-19 Lending from the Fed

Paul Krugman writes Voting G.O.P. Means Voting Against Health Care

Just as a meager investment to address antimicrobial resistance could yield a 2,000% return in the future, so, too, would an immediate modest outlay to finance development of COVID-19 therapeutics. As world leaders gather to formulate a response to the crisis, they must not lose sight of this simple cost-benefit calculus.

LONDON – This week, G20 leaders will convene virtually to discuss the COVID-19 crisis. One hopes that the emergency summit marks the beginning of a thoughtful collective response to this grave challenge. If so, the meeting may turn out to be even more consequential than the London summit hosted by British Prime Minister Gordon Brown in April 2009, which created the framework for a coordinated multilateral response to the global financial crisis.

Having chaired the United Kingdom’s global Review on Antimicrobial Resistance (AMR), I cannot help but think that the current crisis demands a similar undertaking to bring together infectious-disease modeling, economic analysis, and evidence-based solutions. When our findings were published in 2016, we garnered a good deal of attention for...

Leave a Reply

Your email address will not be published. Required fields are marked *